Medicines, Poisons and Therapeutic Goods Regulation 2008
561Requirements for CHO controlled medicines approval
Start here
Get a plain-English read of 561
Turn the raw legal text into a practical explanation grounded in Medicines, Poisons and Therapeutic Goods Regulation 2008.
561 Requirements for CHO controlled medicines approval applications (1) An application by a designated prescriber for an approval to prescribe a controlled medicine for a patient must include the following: (a) the designated prescriber’s name and address; (b) if the application is made on behalf of a group of designated prescribers—the names of the designated prescribers or a description of the group; (c) the medicine, and either— (i) the form, strength and maximum daily dose of the Note Other forms and strengths of the medicine, and a daily dose less than the maximum daily dose, may be prescribed in accordance with s 32.
use (ii) for an approval authorised under a category approval under section 575—details of the approval sought; (d) the patient’s name and home address; (e) the condition from which the patient is suffering that, in the designated prescriber’s opinion, requires treatment with the medicine; (f) whether, in the designated prescriber’s opinion, based on reasonable grounds, the patient is a drug-dependent person in relation to a controlled medicine or prohibited substance. (2) To remove any doubt, the application may include any other information the designated prescriber considers relevant. (3) The chief health officer may ask the designated prescriber for any other information reasonably required to decide the application, including, for example, further information about the patient’s